PLAUR and neoplasm: Since the diselenide bonds could be responsively cleaved by high GSH concentration and the uPA could bind with uPAR, the uPA-PTXD NPs showed GSH-controlled drug release and targeted tumor accumulation, exhibited significant anti-tumor efficacy and reduced systemic toxicity.